BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15496199)

  • 1. Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs.
    Wang Q; Chen Y; Ge Y; Sun J; Shi Q; Ju S; Dai J; Yu G; Zhang X
    Tissue Antigens; 2004 Nov; 64(5):566-74. PubMed ID: 15496199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression analysis of ICOS-L on activated T cells and immature dendritic cells as well as malignant B cells and Grave's-disease-derived thyroid tissues by two novel mAbs against human ICOS-L.
    Wang F; Zhu W; Liu T; Sun Z; Ju S; Ju S; Yu G; Xie W; Deng Z; Lu B; Zhang X
    Tissue Antigens; 2007 Jan; 69(1):62-72. PubMed ID: 17212709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
    Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
    Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.
    Zhou T; Zhang Y; Sun G; Zhang Y; Zhang D; Zhao Y; Chen N
    Exp Mol Pathol; 2006 Apr; 80(2):171-6. PubMed ID: 16413535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.
    Xie F; Wang Q; Chen Y; Gu Y; Shi Q; Ge Y; Yu G; Wu H; Mao Y; Wang X; Zhou Y; Zhang X
    Tissue Antigens; 2006 Apr; 67(4):307-17. PubMed ID: 16634867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of rat OX40 ligand by molecular cloning.
    Akiba H; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1998 Oct; 251(1):131-6. PubMed ID: 9790919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of OX40 expressed on human CD8+ T cells.
    Fujita T; Ukyo N; Hori T; Uchiyama T
    Immunol Lett; 2006 Jul; 106(1):27-33. PubMed ID: 16750861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
    Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
    Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.
    Taylor L; Bachler M; Duncan I; Keen S; Fallon R; Mair C; McDonald TT; Schwarz H
    J Leukoc Biol; 2002 Sep; 72(3):522-9. PubMed ID: 12223520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
    Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
    J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
    Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
    Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
    Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
    Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response.
    Srivastava RM; Varalakshmi Ch; Khar A
    Int Immunol; 2007 May; 19(5):591-607. PubMed ID: 17369187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
    Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM
    Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells.
    Zhang GB; Zhou H; Chen YJ; Ge Y; Xie F; Shi Q; Ma HB; Fei M; Zhang XG
    Tissue Antigens; 2005 Aug; 66(2):83-92. PubMed ID: 16029427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.